Mallory Weiss Syndrome and Diabetes Management

Type 2 diabetes presents ongoing challenges for both patients and healthcare providers. New therapies are pivotal. Among these, ertugliflozin tablets for oral use have gained attention. These tablets are SGLT2 inhibitors. They function by reducing glucose reabsorption...

Is Your Company Too Risk-Averse?

Interventional Orthopedic Insights From the Desk of Regenexx CEO Jason Hellickson Is Your Company Too Risk-Averse? “Your Company is Too Risk-Averse,” says the latest issue of the Harvard Business Review. This article has great insights for anyone running a benefits...

Maximize Your Self-funded Plan by Adding Off-Plan-Year Strategies

A key benefit of having a self-funded health plan is the ability to add benefits at any time of year Having trouble viewing this email? Click here Interventional Orthopedic Insights From the Desk of Regenexx CEO Jason Hellickson Maximize Your Self-funded Plan by...

Why Your Employee is a Costly Repeat Customer in Your Health Plan

The quality of care offered at the right time when an MSK issue happens is key Having trouble viewing this email? Click here Interventional Orthopedic Insights From the Desk of Regenexx CEO Jason Hellickson Why Your Employee is a Costly Repeat Customer in Your Health...